Director at Clinipace
Chris Semple, managing director, joined Crestline in 2011 and is responsible for Crestline’s opportunistic and private credit strategies. He also currently serves on the board of directors of Carepayment Technologies, Leading Pharma, and Urgent Team Holdings, and he is a member of YPO. Prior to Crestline, Semple was vice president in the Special Situations Group for Goldman Sachs where he was responsible for originating, underwriting, executing, and managing middle market debt and equity investment opportunities. Semple also worked as a credit analyst within the Special Opportunities Group for TQA Investors, focusing on liquid credits as well as managing a long-only convertible bond fund.